Very long-term survival implications of heart valve replacement with tissue versus mechanical prostheses in adults < 60 years of age

Article; Proceedings Paper

关键词: BIOPROSTHETIC VALVE;    PERFORMANCE;    OUTCOMES;    COMPLICATIONS;    COMPOSITES;    PERSISTENT;    GUIDELINES;    PREDICTORS;    FAILURE;   

DOI  :  10.1161/CIRCULATIONAHA.106.681429

来源: SCIE

【 摘 要 】

Background - Several centers favor replacing a diseased native heart valve with a tissue rather than a mechanical prosthesis, even in younger adult patients. However, long-term data supporting this approach are lacking. We examined the survival implications of selecting a tissue versus a mechanical prosthesis at initial left-heart valve replacement in a cohort of adults < 60 years of age who were followed for over 20 years. Methods and Results - Comorbid and procedural data were available from 6554 patients who underwent valve replacement at our institution over the last 35 years. Of these, 1512 patients contributed follow-up data beyond 20 years, of whom 567 were adults < 60 years of age at first left-heart valve operation (mean survivor follow-up, 24.0 +/- 3.1 years). Late outcomes were examined with Cox regression. Valve reoperation, often for prostheses that are no longer commercially available, occurred in 89% and 84% of patients by 20 years after tissue aortic and mitral valve replacement, respectively, and was associated with a mortality of 4.3%. There was no survival difference between patients implanted with a tissue versus a mechanical prosthesis at initial aortic valve replacement (hazard ratio 0.95; 95% CI: 0.7, 1.3; P = 0.7). For mitral valve replacement patients, long-term survival was poorer than after aortic valve replacement (hazard ratio 1.4; 95% CI: 1.1, 1.8; P = 0.003), but again no detrimental effect was associated with use of a tissue versus a mechanical prosthesis (hazard ratio 0.9; 95% CI 0.5, 1.4; P = 0.5). Conclusions - In our experience, selecting a tissue prosthesis at initial operation in younger adults does not negatively impact survival into the third decade of follow-up, despite the risk of reoperation.

【 授权许可】

Free